Synthesis of Novel Podophyllotoxin–Benzothiazole Congeners and Their Biological Evaluation as Anticancer Agents
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136033 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Pramukti Nawar Rai'dah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland. Hauptthemen laut MEDLINE: Podophyllotoxin, Benzothiazoles, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Warsaw.
Abstract (Originalsprache)
A series of novel podophyllotoxin derivatives containing benzothiazole scaffolds were synthesized and evaluated for their in vitro cytotoxic activity against five cancer cell lines (MCF-7, SKOV-3, B16F10, LOVO, and HeLa). Two compounds, 7 and 11, which are different only by the absence or presence of the ester group, showed the strongest cytotoxic effect towards all tested cancer cell lines with the IC50 0.68–2.88 µM. In addition, it was demonstrated that these compounds inhibit cancer cell proliferation by inducing G2/M phase arrest in HeLa cells. The structure–activity relationship was analyzed and it confirmed the importance of the core structural features like a dioxolane ring and free-rotating trimethoxyphenyl group for cytotoxicity. Moreover, the R configuration of the ester group at the C-8′ position proved to be substantial since its epimer was inactive. The molecular docking studies revealed that the most potent compounds have a different binding mode to β-tubulin than podophyllotoxin; however, the benzothiazole fragment docked in a similar location as the trimethoxyphenyl group of podophyllotoxin, exhibiting similar hydrophobic interactions. These findings clearly indicate that podophyllotoxin–benzothiazole derivatives could be addressed for further pharmacological studies in anticancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.
- National Centre for Nuclear Research, A. Sołtana 7, 05-400 Otwock, Poland.
- Department of Histology and Embryology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
ORCID-Profile: Pramukti Nawar Rai'dah, Zuzanna Molęda, Armand Budzianowski, Izabela Młynarczuk-Biały, Zbigniew Czarnocki
Förderung
- University of Warsaw
Zitieren
APA
Rai'dah, P. N., Molęda, Z., Osińska, A., Budzianowski, A., Młynarczuk-Biały, I., & Czarnocki, Z. (2025). Synthesis of Novel Podophyllotoxin–Benzothiazole Congeners and Their Biological Evaluation as Anticancer Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136033
Vancouver
Rai'dah PN, Molęda Z, Osińska A, Budzianowski A, Młynarczuk-Biały I, Czarnocki Z. Synthesis of Novel Podophyllotoxin–Benzothiazole Congeners and Their Biological Evaluation as Anticancer Agents. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136033
BibTeX
@article{Raidah2025,
author = {Rai'dah, Pramukti Nawar and Molęda, Zuzanna and Osińska, Aleksandra and Budzianowski, Armand and Młynarczuk-Biały, Izabela and Czarnocki, Zbigniew},
title = {Synthesis of Novel Podophyllotoxin–Benzothiazole Congeners and Their Biological Evaluation as Anticancer Agents},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136033}
}
EUVIMED